251 related articles for article (PubMed ID: 29979199)
1. Use of Hydroxocobalamin (Vitamin B12a) in Patients With Vasopressor Refractory Hypotension After Cardiopulmonary Bypass: A Case Series.
Armour S; Armour TK; Joppa WR; Maltais S; Nelson JA; Wittwer E
Anesth Analg; 2019 Jul; 129(1):e1-e4. PubMed ID: 29979199
[TBL] [Abstract][Full Text] [Related]
2. Hydroxocobalamin for the Treatment of Vasoplegia: A Review of Current Literature and Considerations for Use.
Shapeton AD; Mahmood F; Ortoleva JP
J Cardiothorac Vasc Anesth; 2019 Apr; 33(4):894-901. PubMed ID: 30217583
[No Abstract] [Full Text] [Related]
3. The use of high-dose hydroxocobalamin for vasoplegic syndrome.
Roderique JD; VanDyck K; Holman B; Tang D; Chui B; Spiess BD
Ann Thorac Surg; 2014 May; 97(5):1785-6. PubMed ID: 24792267
[TBL] [Abstract][Full Text] [Related]
4. Vasoplegic syndrome after cardiovascular surgery: A review of pathophysiology and outcome-oriented therapeutic management.
Datt V; Wadhhwa R; Sharma V; Virmani S; Minhas HS; Malik S
J Card Surg; 2021 Oct; 36(10):3749-3760. PubMed ID: 34251716
[TBL] [Abstract][Full Text] [Related]
5. Use of Intravenous Hydroxocobalamin without Methylene Blue for Refractory Vasoplegic Syndrome After Cardiopulmonary Bypass.
Peyko V; Finamore M
Am J Case Rep; 2021 Jun; 22():e930890. PubMed ID: 34143764
[TBL] [Abstract][Full Text] [Related]
6. Hydroxocobalamin as a Rescue Treatment for Refractory Vasoplegic Syndrome After Prolonged Cardiopulmonary Bypass.
Burnes ML; Boettcher BT; Woehlck HJ; Zundel MT; Iqbal Z; Pagel PS
J Cardiothorac Vasc Anesth; 2017 Jun; 31(3):1012-1014. PubMed ID: 27838199
[No Abstract] [Full Text] [Related]
7. Hydroxocobalamin for the treatment of cardiac surgery-associated vasoplegia: a case series.
Shah PR; Reynolds PS; Pal N; Tang D; McCarthy H; Spiess BD
Can J Anaesth; 2018 May; 65(5):560-568. PubMed ID: 29209927
[TBL] [Abstract][Full Text] [Related]
8. Intraoperative Versus Postoperative Hydroxocobalamin for Vasoplegic Shock in Cardiothoracic Surgery.
Khandekar DA; Seelhammer TG; Mara KC; Stephens EH; Wittwer ED; Wieruszewski PM
J Cardiothorac Vasc Anesth; 2023 Dec; 37(12):2538-2545. PubMed ID: 37723020
[TBL] [Abstract][Full Text] [Related]
9. Methylene Blue Monotherapy Compared With Combination Therapy With Hydroxocobalamin for the Treatment of Refractory Vasoplegic Syndrome: ARetrospective Cohort Study.
Feih JT; Rinka JRG; Zundel MT
J Cardiothorac Vasc Anesth; 2019 May; 33(5):1301-1307. PubMed ID: 30606508
[TBL] [Abstract][Full Text] [Related]
10. Vasoplegia During Cardiopulmonary Bypass: Current Literature and Rescue Therapy Options.
Ortoleva J; Shapeton A; Vanneman M; Dalia AA
J Cardiothorac Vasc Anesth; 2020 Oct; 34(10):2766-2775. PubMed ID: 31917073
[TBL] [Abstract][Full Text] [Related]
11. A retrospective analysis of terlipressin in bolus for the management of refractory vasoplegic hypotension after cardiac surgery.
Noto A; Lentini S; Versaci A; Giardina M; Risitano DC; Messina R; David A
Interact Cardiovasc Thorac Surg; 2009 Oct; 9(4):588-92. PubMed ID: 19581293
[TBL] [Abstract][Full Text] [Related]
12. Use of Intravenous Hydroxocobalamin for Vasoplegic Syndrome in Simultaneous Liver-Kidney Transplant: A Case Report.
Weinberg D; Running K; Kalarickal PL; Patel GP
Transplant Proc; 2021 May; 53(4):1300-1302. PubMed ID: 33246585
[TBL] [Abstract][Full Text] [Related]
13. Vasoplegia during cardiac surgery: current concepts and management.
Fischer GW; Levin MA
Semin Thorac Cardiovasc Surg; 2010; 22(2):140-4. PubMed ID: 21092891
[TBL] [Abstract][Full Text] [Related]
14. Hydroxocobalamin or Methylene Blue for Vasoplegic Syndrome in Adult Cardiothoracic Surgery.
Kram SJ; Kram BL; Cook JC; Ohman KL; Ghadimi K
J Cardiothorac Vasc Anesth; 2022 Feb; 36(2):469-476. PubMed ID: 34176677
[TBL] [Abstract][Full Text] [Related]
15. Synthetic Human Angiotensin II for Postcardiopulmonary Bypass Vasoplegic Shock.
Wieruszewski PM; Radosevich MA; Kashani KB; Daly RC; Wittwer ED
J Cardiothorac Vasc Anesth; 2019 Nov; 33(11):3080-3084. PubMed ID: 31060933
[No Abstract] [Full Text] [Related]
16. Predicting the Response of Hydroxocobalamin in Postoperative Vasoplegia in Recipients of Cardiopulmonary Bypass.
Vollmer N; Wieruszewski PM; Martin N; Seelhammer T; Wittwer E; Nabzdyk C; Mara K; Nei SD
J Cardiothorac Vasc Anesth; 2022 Aug; 36(8 Pt B):2908-2916. PubMed ID: 35181236
[TBL] [Abstract][Full Text] [Related]
17. A Reminder of Methylene Blue's Effectiveness in Treating Vasoplegic Syndrome after On-Pump Cardiac Surgery.
Manghelli J; Brown L; Tadros HB; Munfakh NA
Tex Heart Inst J; 2015 Oct; 42(5):491-4. PubMed ID: 26504450
[TBL] [Abstract][Full Text] [Related]
18. Vitamin D and Postoperative Vasopressor Use in Cardiopulmonary Bypass.
Javorski MJ; Kerolos MM; Fareed J; Perez-Tamayo RA
Clin Appl Thromb Hemost; 2018 Nov; 24(8):1322-1326. PubMed ID: 29730947
[TBL] [Abstract][Full Text] [Related]
19. Vitamin C for Vasoplegia After Cardiopulmonary Bypass: A Case Series.
Wieruszewski PM; Nei SD; Maltais S; Schaff HV; Wittwer ED
A A Pract; 2018 Aug; 11(4):96-99. PubMed ID: 29634537
[TBL] [Abstract][Full Text] [Related]
20. Hydroxocobalamin administration for treatment of vasoplegic syndrome associated with cardiopulmonary bypass causes red plasma.
Saifee NH; Sedgwick S; Wu Y
Transfusion; 2020 Mar; 60(3):447-448. PubMed ID: 31829436
[No Abstract] [Full Text] [Related]
[Next] [New Search]
